Overview

Bioequivalence of Orfadin Suspension Compared to Orfadin Capsules, and the Effect of Food on the Bioavailability of the Suspension

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The study is primarily being performed in order to demonstrate bioequivalence between the Orfadin (nitisinone) suspension and the marketed capsule formulation. The study will also contain a comparison of the bioavailability of the suspension given with food and on an empty stomach.

Phase:

Phase 1

Details

Lead Sponsor:

Swedish Orphan Biovitrum

Treatments:

Nitisinone